Alcidion (ASX:ALC) has completed a capital raise

Alcidion (ASX:ALC) has raised funds to continue its growth strategy.

Alcidion is transforming healthcare with smart, intuitive and complementary software products and services that create a unique offering in the global healthcare market. These solutions support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient systems.

Oaklins’ team in Australia acted as lead manager in this transaction.

Service

Funding, debt advisory & ECM

Parties

Talk to the deal team

Justin Lewis

Managing Director

Melbourne, Australia
Oaklins Henslow

View profile Get in touch

Scott McInnes

Managing Director

Melbourne, Australia
Oaklins Henslow

View profile Get in touch

Sebastian Bell

Associate

Melbourne, Australia
Oaklins Henslow

View profile Get in touch

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination

Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Private Equity | Healthcare

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.

Learn more

Biosynex has acquired Para’kito

Healthcare

Biosynex has acquired Para’kito

Biosynex has acquired Para’kito, operated by Hong-Kong based Evergreen Land Ltd. The transaction includes assets and IP and the exclusive right to commercialize the brand in Europe, Africa and South America.

Learn more